Submitted by Anonymous (not verified) on 28 January 2026 - 10:00
Human medicines European public assessment report (EPAR): Tadalafil Lilly, tadalafil, Date of authorisation: 22/03/2017, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tadalafil Lilly, tadalafil, Date of authorisation: 22/03/2017, Revision: 8, Status: Authorised